58 Chapter 4 Table 1: Patient characteristics and outcomes in patients with and without possible bleeding disorder. Characteristic Total group (n=71) ISTH-BAT <6 (n=55) ISTH-BAT ≥6 (n=16) P-value OR (95% CI) Age (years) (Mean; SD) at initial EA treatment 45.4 (4.9) 46.3 (4.8) 42.3 (4.3) 0.004 * - Post EA Bleeding score (ISTH-BAT), median (range) at 2-5years FU 4 (4-10) 4 (4-4) 7 (6-10) Post EA Bleeding score (PBAC) at 2-5years FU Post EA Amenorrhea), n % at 2-5years FU 55 (76%) 45 (82%) 10 (63%) 0.550† 0.76 (0.32-1.85) Post EA Dysmenorrhea), n % at 2-5years FU 16 (23%) 10 (18%) 6 (38%) 0.111 † 2.70 (0.79-9.17) Overall surgical re-intervention, n (%) within 10 years FU 17 (22%) 14 (25%) 3 (19%) Repeat EA, n (%) within 10 years FU 2 (3%) 2 (4%) 0 Re-intervention Hysterectomy, n (%) within 10 years FU Pathology uterus, n 15 (21%) (adenomyosis n=7; myoma n=5; ordinary n=3) 12 (22%) (adenomyosis n=6; myoma n=4; ordinary n=2) 3 (19%) (adenomyosis n=1; myoma n=1; ordinary n=1) 0.104† (adenomyosis p=0.618†) - (0.57 (0.06-5.11)) CI, confidence interval; ISTH-BAT, International Society on Thrombosis and Haemostasis-Bleeding Assessment Tool; IQR, interquartile range; NA, not applicable; OR, odds ratio; PBAC score, pictorial bleeding assessment chart; Surgical re-interventions at 5 years of follow-up (year of re-intervention (number of intervention). * student t test for unpaired data, † Chi-square test. †† Fisher’s exact test ISTH BAT <6 versus ISTH BAT ≥6.
RkJQdWJsaXNoZXIy MTk4NDMw